🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Matching synthetic needs with the existing chemical supply chain can improve access to COVID-19 therapies. See the #OL article by Dinesh Paymode and coworkers: buff.ly/3ms9jbp

US needs drug supply options with holistic approach, says Phlow co-founder. Dr Frank Gupton argues that COVID-19 has shone a light over long-running drug supply issues at CPhI Festival of Pharma online event: ow.ly/GY3f50BKAff #CPhI #festivalpharma

#firesidechat #frankgupton player.vimeo.com/video/464479869

Our joint paper with Medicines for All describing an improved synthesis of MK-4482 (aka EIDD-2801), currently in Phase II clinical trails on symptomatic patients with #COVID19, is out. Check out this work from RCPE and Uni Graz/University of Graz here: bit.ly/3nsHMXT

Congrats to VCU's Medicines for All for winning the outstanding collaboration in technology award from rvatech/ along with partner Phlow Corp. . They demonstrate the "collaborative spirit necessary to achieve breakthrough innovations in technology." VCU celebrates #innovation.

Hear from leaders driving the cluster of advanced pharmaceutical manufacturing in VA - Medicines for All (Medicines for All), Phlow Corporation (Phlow Corp.) and AMPAC Fine Chemicals (Ampac Fine Chemicals an SK pharmteco Company), and learn technologies, products and services which could change the world

Governor Northam Announces Pharmaceutical Manufacturer Civica Inc. to Create 186 New Jobs in City of Petersburg shar.es/aojY5n

richmond.com/opinion/column…

National drug shortage crisis hits Covid vaccine rollout cnb.cx/2KYUfUO Phlow Corp. Civica Rx Ampac Fine Chemicals an SK pharmteco Company

On Medicines for All: "they’re really acting as the R&D partner for us, leveraging their innovative flow chemistry experience and their proprietary process manufacturing technology, to transfer that method over to Phlow Corp.." Story via Richmond magazine.

📻 Frank Gupton, Ph.D., will appear on With Good Reason to talk about Medicines for All. The episode airs in #RVA at 4 p.m. Saturday (2/13) on 88.9 FM VPM. Details: Taking the Shot withgoodreasonradio.org/episode/taking…

Thanks to With Good Reason for its recent episode featuring a conversation with Frank Gupton of VCU Engineering about Medicines for All. The program is not transcribed, but you can learn more at medicines4all.vcu.edu

Thank you to the Phlow Corp. and VCU Medicines for All teams for the opportunity to learn more about their work to strengthen U.S. development of critical medications and fortify our medical supply chain. This research is essential, especially in the wake of the COVID-19 pandemic.

Phlow, USP to establish continuous manufacturing validation lab Phlow Corp. U.S. Pharmacopeia buff.ly/3bwQfnV

Phlow’s partnership with U.S. Pharmacopeia, alongside VCU's Medicines for All, represents another step forward in our efforts to strengthen the U.S. supply chain for #essentialmedicines. Thank you Bloomberg for featuring this important collaboration: bloomberg.com/news/articles/…

We are pleased to support Governor Glenn Youngkin announcement regarding Ampac Fine Chemicals an SK pharmteco Company $25 million investment to expand its facility in Petersburg, Virginia alongside our partners Medicines for All and Civica Rx. Read more: governor.virginia.gov/newsroom/all-r…

Federal pharma ingredient stockpile is under construction in Virginia marketplace.org/2021/10/19/fed…

Everyone deserves equitable access to healthcare. That’s why we engaged partners like @MedsForAll and The University of Manchester to find more affordable, safe materials that generic manufacturers can use to produce medicines at a lower cost.

M4ALL is proud to be a part of this global initiative to increase access to affordable, life-saving treatment for COVID-19. Gates Foundation #manufacturing #covidtreatment #molnupiravir gatesfoundation.org/ideas/media-ce…

Sen. Tim Kaine toured Medicines for All, a VCU initiative, to learn more about reducing the cost to make COVID medications & what can be done to continue the funding to solidify their work, lower drug costs & prepare for the next pandemic. bit.ly/3NPwEBG via @rtdnews